EU Raises Pressure On Pharmaceutical Pollution Of The Environment
A New Ad Hoc Group Is To Be Set Up
Executive Summary
Two EU bodies want to move forward with European Commission proposals on contamination of the environment by pharmaceutical substances.
You may also be interested in...
European Pharma Pushes Back Against ‘Discriminatory’ New EU Drug Pollution Proposals
Medicines for Europe, along with EFPIA and the AESGP, say that the ‘polluter pays’ principle behind proposed new European rules on wastewater treatment would saddle pharmaceutical manufacturers with costs that “jeopardize patient access.”
Drug Shortages, AMR & Cancer High On New EU Commissioner’s Agenda
The new EU commissioner for health has been given a number of high-priority tasks, including medicines supply and tackling antimicrobial resistance. These topics will be taken up by the European Commission’s advisory body, the Pharmaceutical Committee, in its new work plan.
Differences Put Aside As ICH Finalizes Guide On Post Approval Changes
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.